Posts by psm2016
Regeneca Worldwide, A Division Of Vivaceuticals, Inc Voluntarily Recalls RegeneSlim Appetite Control Capsules Due To The Presence Of DMAA That May Pose Possible Health Risk
This is a reprint of an FDA Alert. Recall — Firm Press Release FDA posts press releases and other notices of recalls and market withdrawals from the firms involved as a service to consumers, the media, and other interested parties. FDA does not endorse either the product or the company. Contact Consumer/Media: 949-281-2600 FOR IMMEDIATE…
[...]Deputy Commissioner Sklamberg Describes FDA’s New Powers to Combat Fake Drugs on a Global Scale
FDA Deputy Commissioner Howard Sklamberg, keynote speaker at Interchange 2014, has offered a clear explanation of FDA’s implementation of the Food and Drug Administration Safety and Innovation Act Title VII drug supply chain provisions. On July 9, 2012, President Barack Obama signed the Food and Drug Administration Safety and Innovation Act (FDASIA) in to law.…
[...]Bahamian Pharmacist Who Shipped Drugs for RXNorth Ordered to Face Retrial on Counterfeit Drug Shipping Charges
Andrew Strempler, third from left, holds pharmacy orders. Jan 3, 2002 photo used with permission from the Canadian Press. The pharmacist in the Bahamas who provided order fulfillment for fake online pharmacy pioneer Andrew Strempler and his RXNorth/Mediplan online pharmacies has been ordered by an appeals court in the Bahamas to return to court. Missouri…
[...]Dégardin, Klara, Yves Roggo, and Pierre Margot. “Understanding and fighting the medicine counterfeit market.” Journal Of Pharmaceutical & Biomedical Analysis 87, (January 18, 2014): 167-175.
Abstract Medicine counterfeiting is a serious worldwide issue, involving networks of manufacture and distribution that are an integral part of industrialized organized crime. Despite the potentially devastating health repercussions involved, legal sanctions are often inappropriate or simply not applied. The difficulty in agreeing on a definition of counterfeiting, the huge profits made by the counterfeiters…
[...]da Justa Neves, Diana Brito, Ravane Gracy Ament Marcheti, and Eloisa Dutra Caldas. “Incidence of anabolic steroid counterfeiting in Brazil.” Forensic Science International 228, no. 1-3 (May 10, 2013): e81-e83.
AbstractThis retrospective study reports data obtained from the National Institute of Criminalistics of the Brazilian Federal Police Department (DPF) on 3676 anabolic products seized between 2006 and 2011. Anabolic androgenic steroids (AAS) were declared on the labels of 96.2% of the products. About one third of the products declared to be from Paraguay, and 14.3%…
[...]“Operation Pangea VI: combating sale of unapproved medicines.” WHO Drug Information 27, no. 3 (September 2013): 227.
Abstract: The article reports on a 2013 decision which the U.S. Food and Drug Administration and several other international law enforcement and regulatory agencies made to take legal and regulatory action against more than 9,600 web sites from various countries that illegally market unproven prescription drugs to consumers. "Operation Pangea VI: combating sale of unapproved…
[...]Ganor, Boaz, and Miri Halperin Wernli. “The Infiltration of Terrorist Organizations Into the Pharmaceutical Industry: Hezbollah as a Case Study.” Studies In Conflict & Terrorism 36, no. 9 (September 2013): 699-712.
Abstract: Criminal syndicates and terrorist organizations are inherently different, one motivated by profit and the other by political goals. Yet their difference enables them to cooperate for their mutual benefit. Nowhere has this been more evident than in the drug trade; from harvesting and trafficking in illegal substances, it has been an easy transition to counterfeiting…
[...]Mackey, Tim K.*, and Bryan A. Liang*. “Pharmaceutical digital marketing and governance: illicit actors and challenges to global patient safety and public health.” Globalization & Health 9, no. 1 (November 2013): 1-21.
BackgroundDigital forms of direct-to-consumer pharmaceutical marketing (eDTCA) have globalized in an era of free and open information exchange. Yet, the unregulated expansion of eDTCA has resulted in unaddressed global public health threats. Specifically, illicit online pharmacies are engaged in the sale of purportedly safe, legitimate product that may in fact be counterfeit or substandard. These…
[...]Glass, Beverley D. “Counterfeit drugs and medical devices in developing countries.” Research & Reports In Tropical Medicine 5, (March 2014): 11-22.
Abstract: The World Health Organization has reported that counterfeit medicines potentially make up more than 50% of the global drug market, with a significant proportion of these fake products being encountered in developing countries. This occurrence is attributed to a lack of effective regulation and a weak enforcement capacity existing in these countries, with an…
[...]Binkowska-Bury, Monika, et al. “Counterfeit medicines in Poland: opinions of primary healthcare physicians, nurses and lay persons.” Journal Of Clinical Nursing 22, no. 3/4 (February 2013): 559-568.
Aims and objectives. To gain information concerning disparities in the understanding of the counterfeit medicines phenomenon between healthcare workers and lay persons. Background. Central-eastern Europe is facing significant challenges in combating a multi-billion euro, and often lethal, trade in counterfeit medicines. It is a major challenge especially for primary healthcare workers to expand the understanding…
[...]